AVITA Medical (RCEL) Revenue & Revenue Breakdown
AVITA Medical Revenue Highlights
Latest Revenue (Y)
$50.56M
Latest Revenue (Q)
$18.41M
Main Segment (Y)
Lease Revenue
Main Geography (Y)
UNITED STATES
AVITA Medical Revenue by Period
AVITA Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $50.56M | 72.96% |
| 2021-06-30 | $29.23M | 41.44% |
| 2020-06-30 | $20.67M | 1546.56% |
| 2018-06-30 | $1.26M | 6.31% |
| 2017-06-30 | $1.18M | 17.83% |
| 2016-06-30 | $1.00M | 1.66% |
| 2015-06-30 | $985.65K | -63.27% |
| 2014-06-30 | $2.68M | -4.68% |
| 2013-06-30 | $2.81M | -16.03% |
| 2012-06-30 | $3.35M | 0.50% |
| 2011-06-30 | $3.34M | 45.24% |
| 2010-06-30 | $2.30M | -2.97% |
| 2009-06-30 | $2.37M | 96.64% |
| 2008-06-30 | $1.20M | 52.17% |
| 2007-06-30 | $790.99K | -10.46% |
| 2006-06-30 | $883.39K | 127.05% |
| 2004-06-30 | $389.08K | 100.23% |
| 2002-12-31 | $194.32K | 100.00% |
| 2001-12-31 | - | 100.00% |
| 2000-12-31 | - | 100.00% |
| 1999-12-31 | - | -100.00% |
| 1998-12-31 | $582.97K | 100.00% |
| 1997-12-31 | - | 100.00% |
| 1996-12-31 | - | 100.00% |
| 1995-12-31 | - | 100.00% |
| 1994-12-31 | - | 100.00% |
| 1993-12-31 | - | - |
AVITA Medical generated $50.56M in revenue during NA 2022, up 72.96% compared to the previous quarter, and up 5045.97% compared to the same period a year ago.
AVITA Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $18.41M | -5.83% |
| 2024-09-30 | $19.55M | 28.63% |
| 2024-06-30 | $15.20M | 36.84% |
| 2024-03-31 | $11.10M | -21.78% |
| 2023-12-31 | $14.20M | -33.12% |
| 2023-09-30 | $21.23M | 20.29% |
| 2023-06-30 | $17.65M | 67.26% |
| 2023-03-31 | $10.55M | 11.58% |
| 2022-12-31 | $9.46M | -33.49% |
| 2022-09-30 | $14.22M | 17.75% |
| 2022-06-30 | $12.07M | 19.83% |
| 2022-03-31 | $10.07M | 5.53% |
| 2021-12-31 | $9.55M | 35.98% |
| 2021-09-30 | $7.02M | -31.87% |
| 2021-06-30 | $10.30M | -10.70% |
| 2021-03-31 | $11.54M | 74.34% |
| 2020-12-31 | $6.62M | -6.36% |
| 2020-09-30 | $7.07M | 25.81% |
| 2020-06-30 | $5.62M | -10.89% |
| 2020-03-31 | $6.30M | 35.73% |
| 2019-12-31 | $4.64M | -3.54% |
| 2019-09-30 | $4.82M | 130.02% |
| 2019-06-30 | $2.09M | - |
| 2019-03-31 | $2.09M | 227.82% |
| 2018-12-31 | $638.58K | -2.54% |
| 2018-09-30 | $655.25K | 151.18% |
| 2018-06-30 | $260.87K | 14.90% |
| 2018-03-31 | $227.05K | -4.25% |
| 2017-12-31 | $237.13K | -0.50% |
| 2017-09-30 | $238.32K | - |
AVITA Medical generated $18.41M in revenue during Q4 2024, up -5.83% compared to the previous quarter, and up 86.71% compared to the same period a year ago.
AVITA Medical Revenue Breakdown
AVITA Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|
| Lease Revenue | $358.00K | - | - | - |
| Foreign | - | $160.00K | $171.00K | - |
| Recell System | - | - | $435.00K | - |
AVITA Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Lease Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lease Revenue | $194.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Recell System | - | $399.00K | $408.00K | $416.00K | $432.00K | $435.00K | $435.00K | $435.00K | $4.10M | - | - | - | - |
| Foreign | - | - | - | - | $39.00K | $15.00K | $30.00K | $10.00K | - | - | - | - | - |
AVITA Medical's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Lease Revenue (100.00%).
AVITA Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|
| UNITED STATES | $62.16M | $33.26M | $28.95M | $13.80M |
| AUSTRALIA | $312.00K | - | - | - |
| European Union | $155.00K | - | - | - |
| JAPAN | $1.43M | - | - | - |
AVITA Medical's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (97.04%), JAPAN (2.23%), AUSTRALIA (0.49%), and European Union (0.24%).
Quarterly Revenue by Country
| Country | Dec 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $18.00M | $12.96M | $10.99M | $9.43M | $8.59M | $9.00M | $8.28M | $7.40M | $10.24M | $8.72M | $5.02M | $4.97M | - |
| JAPAN | $193.00K | $581.00K | $708.00K | $1.02M | - | - | - | - | - | - | - | - | - |
| European Union | $1.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| AUSTRALIA | $180.00K | $61.00K | $33.00K | $62.00K | - | - | - | - | - | - | - | - | - |
| U S | - | - | - | - | - | - | - | - | $6.92M | - | - | - | - |
AVITA Medical's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (97.96%), JAPAN (1.05%), AUSTRALIA (0.98%), and European Union (0.01%).
AVITA Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VREX | Varex Imaging | $811.00M | $199.80M |
| TMDX | TransMedics Group | $441.54M | $121.62M |
| TMCI | Treace Medical Concepts | $209.36M | $68.71M |
| AXGN | AxoGen | $187.34M | $49.41M |
| SIBN | SI-BONE | $167.18M | $49.00M |
| RXST | RxSight | $139.93M | $40.21M |
| LUNG | Pulmonx | $83.79M | $22.54M |
| NPCE | NeuroPace | $79.91M | $21.47M |
| SGHT | Sight Sciences | $79.87M | $19.07M |
| IRMD | IRadimed | $73.24M | $19.51M |
| TELA | TELA Bio | $69.30M | $17.65M |
| CVRX | CVRx | $51.29M | $15.34M |
| RCEL | AVITA Medical | $50.56M | $18.41M |
| APYX | Apyx Medical | $48.10M | $14.22M |
| CLPT | ClearPoint Neuro | $31.39M | $7.77M |
| DCTH | Delcath Systems | $31.02M | $15.10M |
| OFIX | Orthofix Medical | - | $215.66M |